TriHealth
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, TriHealth sits in the top decile of US sponsors by registered trial count (#277 of 15,742 sponsors by registered trial count).
TriHealth: 81 sponsored US clinical trials, 2 recruiting.
TriHealth sponsors 81 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 62 completed. 13 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Resected Polyp, with 1 trials.
Top-decile sponsor footprint
TriHealth ranks in the top decile of sponsors by registered trial count (#277 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
62 of 76 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
81 total, page 1 of 2
Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery
NCT06843538
Histologic Comparison of Ablative Techniques for Endometriosis
NCT06414083
Impact of Preop Video on Patient Anxiety
NCT05633901
A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections
NCT07387315
Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial
NCT07260825
Impact of Defecation Posture on Ease of Bowel Movements in Patients With a Rectocele
NCT06252714
Impact of Defecation Posture on Ease of First Bowel Movement Following Posterior Repair
NCT06253689
Cold Saline Irrigation Before Endobronchial Biopsy
NCT06373224
Use of a Dual-agent Local Analgesic (Bupivacaine-meloxicam) for Abdominal Incisions in Patients Undergoing Retropubic Mid-urethral Sling Surgery
NCT05702827
Leg Elevation to Prevent Hypotension During Labor
NCT05674838
Silver-Coated vs Standard Catheter for UTI Prevention
NCT05408533
Peppermint Oil for Urinary Retention
NCT05259800
Pre-epidural Sequential Compression Devices (SCDs) to Prevent Hypotension During Labor
NCT05250960
Same Day Discharge Following Pelvic Reconstructive Surgery
NCT04804826
Patient Perspective of Telemedicine in Gynecology Oncology
NCT04624165
A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection
NCT04392232
Clinical Utility of Postoperative Hemoglobin Testing
NCT04170764
In-office Assessment of Voiding Function Following Botox Injection for Overactive Bladder
NCT04155593
His Bundle Recording From Subclavian Vein
NCT04115735
Urinary Track Infection Prevention After Urogynecological Surgery
NCT03818321
Utilization of the Mirror During Pelvic Exams
NCT03785548
The Effects of Mindfulness-based Stress Reduction in Interstitial Cystitis Patients
NCT03722992
Female Patient Preferences Regarding Physician Gender
NCT03811340
Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU
NCT03712891
Vaginal Preparation Prior to Hysterectomy
NCT03412734
Postoperative Environment on Pain Following Pelvic Reconstructive Surgery
NCT03379753
Preoperative IV Versus Oral Acetaminophen
NCT03468920
Detection Rate of Serrated Adenomas in Screening Colonoscopy
NCT03442270
Accuracy of Endoscopists in Predicting Polyp Pathology
NCT03477318
Dynamic Magnetic Resonance Imaging Before and After Vaginal Prolapse Repair
NCT03315715
Apical Support During Hysterectomy for Pelvic Organ Prolapse-NSQIP Analysis.
NCT03421067
Apical Support During Hysterectomy for Pelvic Organ Prolapse
NCT03379246
Hepatitis C Education for Pregnant Women With Opiate Dependence - Phase 2
NCT03320889
Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1
NCT03245931
Weighted Blankets With Infants With NAS
NCT03113656
Alkaline Phosphatase Level in Pregnancy and Its Association With Birth Weight
NCT03187938
Neuroprognostication Using Optic Nerve Sheath Diameter
NCT03195881
Impact of Diet on Functional Gastrointestinal Symptoms
NCT03102411
Urodynamic Studies Prior to Surgery for Stress Urinary Incontinence
NCT03107130
Self-discontinuation of a Transurethral Catheter
NCT02996968
Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation
NCT02584088
Pharmacogenomics Information in Enhancing Post-operative Total Joint Replacement Pain Management: a Pilot Study
NCT02711592
The Effects of Sacral Neuromodulation for Urinary Urgency, Frequency, and Urge Incontinence
NCT02776475
Effect of Multimodal Analgesia on Pain With Insertion of Levonorgestrel-releasing IUD
NCT02799641
Intrapartum Effect of Vancomycin on Rectovaginal GBS Colonization
NCT02814318
Uterosacral Ligament Suspension vs Robotic Sacrocolpopexy
NCT02741830
Maintaining Patency in BioFlo Implanted Port Catheters With Saline Only Flushes
NCT02923830
Uterosacral Ligament Suspension Clip
NCT02700997
Maternal Smoking During Pregnancy and Female Fetal Testosterone Levels
NCT02610751
Incidence of Obstetric Anal Sphincter Injuries After a Protection Training
NCT02952404
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 4 |
| Phase 3 | 4 |
| Phase 4 | 9 |
Therapeutic Areas
Where TriHealth enrollment is open (later-stage tilt)
2 recruiting of 81 indexed (2% open); 62 completed (77%).
Phase mix: 13 late (III/IV) vs 5 early (I/II) (later-stage heavy).
Top condition: Resected Polyp (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
TriHealth: open-pipeline peers nationwide
Peers matched on 81 registered trials and 2% open enrollment, not the therapeutic-area sidebar.
TriHealth sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 81 trials (± recruiting share)
- EMD Serono Research & Development Institute · 81 trials · 11% recruiting
- The University of Tennessee, Knoxville · 81 trials · 7% recruiting
- Christiana Care Health Services · 82 trials · 5% recruiting
- UCB Biopharma SRL · 82 trials · 20% recruiting
Sponsors near 2% open enrollment (± trial volume)
- Children's Healthcare of Atlanta · 3% recruiting · 80 trials
- Harvard School of Public Health (HSPH) · 3% recruiting · 40 trials
- Ethicon Endo-Surgery · 3% recruiting · 39 trials
- Cumberland Pharmaceuticals · 2% recruiting · 43 trials
Related
What to do with this TriHealth page
81 registered trials is a research-attention snapshot, not an endorsement of TriHealth or any single study.
- 2 of TriHealth's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Resected Polyp is the condition TriHealth studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Resected Polyp trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
TriHealth pipeline card: 81 registered trials from official public datasets.Report a data error.